Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects
- PMID: 17927751
- DOI: 10.1111/j.1365-2672.2007.03579.x
Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects
Abstract
Aims: Colonic metabolism of lactose may play a role in lactose intolerance. We investigated whether a 2-week supplementation of Bifidobacterium longum (in capsules) and a yogurt enriched with Bifidobacterium animalis could modify the composition and metabolic activities of the colonic microbiota in 11 Chinese lactose-intolerant subjects.
Methods and results: The numbers of total cells, total bacteria and the Eubacterium rectale/Clostridium coccoides group in faeces as measured with fluorescent in situ hybridization and the faecal beta-galactosidase activity increased significantly during supplementation. The number of Bifidobacterium showed a tendency to increase during and after supplementation. With PCR-denaturing gradient gel electrophoresis, in subjects in which B. animalis and B. longum were not detected before supplementation, both strains were present in faeces during supplementation, but disappeared after supplementation. The degree of lactose digestion in the small intestine and the oro-caecal transit time were not different before and after supplementation, whereas symptom scores after lactose challenge decreased after supplementation.
Conclusions: The results suggest that supplementation modifies the amount and metabolic activities of the colonic microbiota and alleviates symptoms in lactose-intolerant subjects. The changes in the colonic microbiota might be among the factors modified by the supplementation which lead to the alleviation of lactose intolerance.
Significance and impact of the study: This study provides evidence for the possibility of managing lactose intolerance with dietary lactose (yogurt) and probiotics via modulating the colonic microbiota.
Similar articles
-
[Effect of probiotics and yogurt on colonic microflora in subjects with lactose intolerance].Wei Sheng Yan Jiu. 2006 Sep;35(5):587-91. Wei Sheng Yan Jiu. 2006. PMID: 17086711 Chinese.
-
Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults.J Mol Microbiol Biotechnol. 2008;14(1-3):128-36. doi: 10.1159/000106092. J Mol Microbiol Biotechnol. 2008. PMID: 17957120 Clinical Trial.
-
Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.Eur J Clin Nutr. 2008 May;62(5):584-93. doi: 10.1038/sj.ejcn.1602761. Epub 2007 Apr 18. Eur J Clin Nutr. 2008. PMID: 17440520 Clinical Trial.
-
The role of colonic metabolism in lactose intolerance.Eur J Clin Invest. 2008 Aug;38(8):541-7. doi: 10.1111/j.1365-2362.2008.01966.x. Eur J Clin Invest. 2008. PMID: 18573099 Review.
-
Probiotics and functional gastrointestinal disorders in children.J Pediatr Gastroenterol Nutr. 2009 Apr;48 Suppl 2:S107-9. doi: 10.1097/MPG.0b013e3181a1603a. J Pediatr Gastroenterol Nutr. 2009. PMID: 19300120 Review.
Cited by
-
Biochemical Engineering Approaches for Increasing Viability and Functionality of Probiotic Bacteria.Int J Mol Sci. 2016 Jun 2;17(6):867. doi: 10.3390/ijms17060867. Int J Mol Sci. 2016. PMID: 27271598 Free PMC article. Review.
-
Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook.Probiotics Antimicrob Proteins. 2023 Nov 18. doi: 10.1007/s12602-023-10189-w. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37979040
-
The importance of cohort studies in the post-GWAS era.Nat Genet. 2018 Mar;50(3):322-328. doi: 10.1038/s41588-018-0066-3. Epub 2018 Mar 6. Nat Genet. 2018. PMID: 29511284
-
Functional yogurt aims to protect against the aflatoxin B1 toxicity in rats.Toxicol Rep. 2020 Oct 21;7:1412-1420. doi: 10.1016/j.toxrep.2020.10.012. eCollection 2020. Toxicol Rep. 2020. PMID: 33102145 Free PMC article.
-
A New β-Galactosidase from the Antarctic Bacterium Alteromonas sp. ANT48 and Its Potential in Formation of Prebiotic Galacto-Oligosaccharides.Mar Drugs. 2019 Oct 23;17(11):599. doi: 10.3390/md17110599. Mar Drugs. 2019. PMID: 31652852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials